GJD2 and autoimmune type 1 diabetes: Glibenclamide also promotes islet expression and function of connexin 36 (Cx36) [2–5], a gap junction protein which significantly contributes to control the secretion and survival of pancreatic beta cells, including under conditions which are thought to prevail in the islet environment at the onset of autoimmune type 1 diabetes [6].